View Article

  • Virtual Screening of Physicochemical and Pharmacokinetic Parameters of Selected Bryophyllum Pinnatum Constituents

  • 1Department of Pharmaceutics, Maratha Mandal College of Pharmacy, Belgaum
    2Department of Pharmaceutical Chemistry, KLE college of Pharmacy, Belgaum
    3Department of Pharmaceutics, Rani Chennamma College of Pharmacy, Belgaum.
     

Abstract

The aim of this study is to determine physicochemical properties and drug likeness of selected plant constituents from Bryophyllum pinnatum by computational screening and to predict pharmacokinetic properties of selected plant constituents from Bryophyllum pinnatum by computational methods. Most of the constituents obeyed Lipinski’s rule and displayed drug like properties. The same constituents where also evaluated for ADME parameters using Qik Prop module of Schrodinger molecular modeling software. Lipinski's rule of five, which is represented by a numerical value known as the drug likeness score—a collective property that encompasses a compound's physicochemical properties, pharmacokinetics, and pharmacodynamics was used to calculate a number of molecular parameters. Mol Soft software was used to calculate the drug likeness model score. The majority of the 38 chemical constituents of Bryophyllum pinnatum that were screened had a positive drug likeness score and ?1 Lipinskis rule violations. Two commercial anti-inflammatory medications, ibuprofen and diclofenac, with drug likeness scores of 0.59 and 0.65, were then compared to this data. This suggests that these particular chemical components might have strong oral bioavailability and favorable drug-like characteristics. From the data obtained, most of the chemical constituents lie in the recommended ranges and have the potential of forming lead molecules with good oral bioavailability

Keywords

Bryophyllum pinnatum, Lipinski’s rule of five, Molsoft, ADME, Schrodinger, pharmacokinetic, physicochemical.

Introduction

Medicinal plants have been known since ages and esteemed as rich source of therapeutic agents, thus utilized in preventing and treating various diseases and ailments. Despite of advancement in drug industry and drug products, about 75% of world population rely on traditional plant products for healing. Traditionally, Bryophyllum pinnatum has been noted for its versatile medicinal properties.1

 Bryophyllum pinnatum is a succulent and perennial plant mostly found at tropical and subtropical areas. The species is native to Madagascar. Bryophyllum pinnatum is also known as Kalanchoe pinnata. Some of the common names for these herbs are as follows: air plant, cathedral bells, miracle leaf, devils backbone.2

Taxonomy:

Kingdom: Plantae

Class: Dicotyledon

Family: Crassulaceae

Genus: Bryophyllum.3

Description of plant:

The plant grows up to 150cm(1-1.5m) in height and leaves grow 10-30cm long. The lower leaves differentiate from upper leaves of plant such that the lower leaves are simple and dark green in color while the upper leaves are 3-7 foliated, long petiolate, with characteristic odour, bitter taste and thick4.  Flowers are cymose, unisexual, regular and pendent with large spreading panicles. Petals are as sepals, reddish-purple in color, while sepals are 25-55mm long, red striated with base green. The fruits are follicles, contain a few seeds. These seeds are small and oblong in shape with smooth surface and brownish in color. The Bryophyllum  pinnatum plant flowers in Nov-Mar and produce fruits in April.           

Pharmacological Actions

The  Bryophyllum pinnatum shows various pharmacological actions such as anti-inflammatory, antidiabetic, anticancer, analgesic, antipyretic, antiulcer, astringent, antiseptic, hepatoprotective, antileishmanial, antioxidant, wound healing activity, antibacterial, antituberculosis, antihypertensive, tocolytic agent, CNS depressant, anxiolytic, neurosedative, insecticidal, immunomudulatory agent, antiallergic, antimicrobial, hepatoprotective, antiurolithic, diurectic, anticonvulsant, uterine relaxant, muscle relaxant, antimalarial, carminative, antigout.4,5,6,7

Chemical Constituents Of Bryophyllum Pinnatum

 Bryophyllum pinnatum is rich in various phytocontituents such as alkaloids, flavonoids, steroids, triterpenes, phenanthrenes, bufadienolides, cardienolides, lipids, glycosides. The leaves are concentrated with majority of bufadienolides and cardiac glycosides. From aerial parts of plant Phenolic acids such as syringic acid, caffeic acid, 2-4-hydroxy-3-methoxy cinnamic acid, etc have been isolated. Flavanoids are rich in leaves mainly quercetin and kaempferol glycosides and few flavone glycosides i.e., luteolin, diosmetin. The plant also showed the presence of triterpenes such as alpha amyrin, beta amyrin, alpha amyrin acetate, beta amyrin acetate, taraxerone, etc. and phytosterols such as stigmast-24-enol, 5-methylerogost-24(28)-enol, etc. Bryophyllum pinnatum possessed high content of mallic acids, carboxylic acids such as oxalic acids, citric acid, isocitric acid, etc.7 U. Rosemary et.al, performed ethanolic extraction of leaves obtained from Bryophyllum pinnatum, 3,5-dihydroxy-6-methyl-2,3-dihydroxy-4H-pyran-4-one showed anticancer activity, alpha-D-Glucopyranoside methyl possessed anti-tuberculosis, antioxidant and anticonvulsant activities, n-Hexadecanoic acid was effective against rheumatism and inflammation, oleic acid decreased risk of breast cancer and decreased blood pressure.6 C. Lucas et.al, carried out ethanolic extraction of Bryophyllum pinnatum. The   flavonoids such as rutin, quercetin, luteolin-7-o-beta-o-glusoide were detected. The study revealed that ethanolic extraction of of  Bryophyllum pinnatum leaves is effective as topical anti-inflammatory for acute and chronic inflammation conditions.8 M. Afzal et.al, isolated a steroidal derivative Stigmast-4,20 (21),23-trien-3-one from Bryophyllum pinnatum leaves. This compound was evaluated for anti-inflammatory activity in carrageenan induced paw edema model and was capable of reducing inflammation.9 Ogidigo.J.O.et.al, performed In-silico molecular docking and pharmacokinetic studies of selected constituents from Bryophyllum pinnatum. Patuletin, luteolin, kaempferol and acacetin passed the Lipinski’s rule of five and showed good binding scores and considerable drug likeness.10 Literature survey revealed that there is a lack of computational studies on virtual screening of selected phytoconstituents from Bryophyllum pinnatum plant, to investigate its physicochemical and ADME properties. Hence, in this context, in the current research work, we aim at virtually screening some phytoconstituents from Bryophyllum pinnatum plant for various physicochemical and pharmacokinetic parameters.

METHODOLOGY

Physicochemical properties and drug likeness

Drug likeness score is determined from molecular properties i.e molecular weight, number of hydrogen bond donors, number of hydrogen bond acceptors, LogP and polar surface area by Molsoft online server.

ADME predictive study

Various ADME parameters of all the selected chemical constituents of Brophyllum pinnatum were calculated by using Qik Prop module of the Schrodinger molecular modeling software. These parameters were then compared with the recommended values of the Qik Prop properties mentioned in the Qik Prop User Manual.

       
            Steps involved in research methodology.png
       

Figure 2: Steps involved in research methodology

RESULTS AND DISCUSSION

A] Determination Of Physicochemical Properties And Drug Likeness Of Selected Chemical Constituents From   Bryophyllum Pinnatum

Lipinski’s Rule Of 5

Lipinski’s rule of 5 or Pfizer rule of 5 or rule of 5 is a thumb rule which postulates whether a drug is orally active in humans or not. This rule was worked out by Christopher A. Lipinski in 1997.11

Components Of Rule Of 5:

Lipinski’s rule of 5 intends that no orally active drug should show more than 1 violation for following norms:

  • No more than 5 hydrogen bond donors
  • No more than 10 hydrogen bond acceptors
  • Molecular weight of drug should be less than 500
  • Log P valve should not exceed more than 5

Since all numbers are multiple of 5, thus contributes to name “RULE OF 5”11,12

       
            Lipinski’s Rule of Five.png
       

Figure 3: Lipinski’s Rule of Five

Various molecular parameters were calculated based on the Lipinski’s rule of five, which is represented by a numerical value called as drug likeness score, that is a collective property encompassing physicochemical properties, pharmacokinetics and pharmacodynamics of a compound. The drug likeness model score was determined by MolSoft software. Among the 38 chemical constituents of Bryophyllum pinnatum that were screened, maximum constituents have shown ?1 number of violations of the Lipinskis rule and a positive drug likeness score. This data was then compared with two commercial anti-inflammatory drugs, diclofenac and ibuprofen having drug likeness score 0.59 and 0.65. This indicates that these selected chemical constituents may have good drug like features and potent oral bioavailability. Results are shown in Table 1.

B] Determination of Pharmacokinetic Properties of Selected Chemical Constituents from Bryophyllum Pinnatum

Pharmacokinetics Studies (Adme Studies)

Pharmacology is categorized into 2 groups: Pharmacodynamics and Pharmacokinetics. Pharmacodynamics is defined as study of effect of drug on body (what the drug does to body). Pharmacokinetics is study of effect of body on drug or is also defined as movement of drug within body and excretion from body (what body does to the drug).The term Pharmacokinetics is coined by Leslie Benet. In order to understand the concept of pharmacokinetics, it is grouped into 4 phases of drugs movement i.e., absorption, distribution, metabolism and excretion (ADME). ADME of drug depends on various properties of drug such as molecular weight, chemical structure, chemical space, degree of ionization, lipophilicity, water solubility, etc. Majority of compounds lack these properties, thus ADME studies are conducted priorily in order to eliminate such compounds. The assessment of ADME is an important part during various stages of drug development such as drug discovery, preclinical and clinical stage, as it determines the drug efficacy, safety and toxicity. About 80% of investigational new drugs are ruled out during drug development process because of undesirable ADME and toxicity characteristics. Most of the Pharmaceutical companies possess hundreds – thousands of potential drugs, but are not FDA approved due to undesirable properties.13

Absorption: Absorption is the movement of drug from its site of administration into circulation. When a drug is administered through oral route, the drug reaches the liver via hepatic portal vein after the drug passes out of Gastrointestinal tract. The drug moves from liver into the blood. Poor absorption of drug likely occurs if the drug has more than      

  • 5H-bond donors
  • 10H- bond acceptors
  • Molecular weight more than 500 Daltons
  • Log P greater than 5

The amount of drug absorbed from the site of absorption evaluates the bioavailability of drug at site of action.

Distribution: The distribution of drug involves its movement into, through, and out of body compartments. Once the drug enters into systemic circulation by absorption, it gets distributed to various organs and muscles. Distribution pattern of drug depends on factors like:

  • Lipid solubility
  • Ionisation at physiological pH
  • Extent of binding to plasma and tissue proteins
  • Presence of tissue specific transporters
  • Difference in regional blood flow

Metabolism: In this process the drug gets converted into metabolites through enzymes. It converts non polar compounds to polar compounds, so that excretion process takes place eliminating the reabsorption of compounds in renal tubules. The converted metabolites may be either active or inactive. This process may either increase or decrease parent drugs activity.

If the drugs activity increases, then the metabolite is active and if drugs activity decreases then the metabolite is inactive.

Excretion: The body excretes metabolites and remaining drug through kidney and other organs such as lungs and skin. If the drug is not completely excreted from body, the remaining traces of body may cause adverse reactions. Drugs and their metabolites are excreted in urine, faeces, exhaled air, saliva, sweat and milk.

Toxicity: The ADME studies includes toxicity studies to calculate Maximum therapeutic dose and minimum toxic dose.13,14,15

The pharmacokinetic parameters of selected chemical constituents from  Bryophyllum pinnatum, were calculated by using QikProp module of Schrodinger molecular modeling software and the data obtained was verified with QikProp manual. The recommended ranges for different ADME parameters are as follows: CNS: predicted central nervous system,-2 to +2, dipole: computed dipole moment of the molecule,1.0-12.5, volume: total solvent-accessible volume in cubic angstroms using a probe with a 1.4angstroms radius,500-2000, QPlogPC16: predicted hexadecane/gas partition coefficient,4.0-18.0, QPlogPoct: predicted octanol/gas partition coefficient,8.0-35.0, QPlogPw: predicted water/gas partition coefficient,4.0-45.0, QPlogPo/w: predicted octanol/water partition coefficient,-2.0-6.5, QPlogS: predicted aqueous solubility,-6.5-0.5, QPlogHERG: predicted IC50 value for blockage of HERG K+ channels,below-5, QPPCaco: predicted apparent Caco-2 cell permeability in nm/sec,<25>500 great, QPlogBB: predicted brain/blood partition coefficient,-3.0-1.2, QPPMDCK: predicted apparent MDCK cell permeability in nm/sec,<25poor>500great, QPlogKp: predicted skin permeability,     -8.0-1.0, QPlogKhsa: prediction of binding to human serum albumin,-1.5-1.5, %HOA: predicted human oral absorption on 0 to 100% scale,>80% is high <25>Table 2. Quercitrin, isoquercitrin, rutin, myricitrin, astragalin, kaempferitrin, thesiuside and misquelianin showed poor HOA. Results shown in Table 2.

 


Table 1. Physicochemical parameters and drug likeness of selected chemical constituents from  Bryophyllum pinnatum

 

Selected Plant Constituent

MW

HBA

HBD

Log P

PSA

Rule of 5 violation

Drug likeness

 

<500>

? 10

? 5

? 5

-

? 1

>0

 

Bryophyllin A

472.21

8

2

2.09

86.32

0

0.67

 

Bryophyllin B

488.20

9

3

1.50

109.03

0

0.87

 

Bryophyllin C

474.23

8

3

1.79

89.28

0

0.83

 

Bryotoxin A

618.27

12

4

0.28

145.01

2

1.06

 

Bryotoxin B

488.20

9

3

0.51

102.32

0

0.68

 

Kaempferol

286.05

6

4

1.61

87.13

0

0.50

 

Astragalin

448.10

11

7

-0.12

152.24

2

0.67

 

Friedein

426.39

1

0

7.44

13.36

1

-0.43

 

Rutin

610.15

16

10

-1.55

213.63

3

0.91

 

Quercetin

302.04

7

5

1.19

102.61

0

0.52

 

Luteoin

286.05

6

4

2.78

89.05

0

0.38

 

Isoquercetin

464.10

12

8

-0.54

167.72

2

0.68

 

Alpha amyrin

426.39

1

1

7.77

15.73

1

0.10

 

Alpha amyrin acetate

468.40

2

0

8.29

20.32

1

0.57

 

Beta amyrin

426.39

1

1

7.95

15.73

1

-0.22

 

Beta amyrin acetate

468.40

2

0

8.47

20.32

1

0.27

 

Afzelin

432.11

10

6

0.74

134.93

1

0.77

 

Glutinol

426.39

1

1

7.97

15.73

1

-0.41

 

Pseudo

Taraxasterol

426.39

1

1

8.15

15.73

1

-0.09

 

Taraxasterol

426.39

1

1

8.11

15.73

1

-0.90

 

Beta sitosterol

414.39

1

1

8.45

16.28

1

0.78

 

Kaempferitrin

578.16

14

8

-0.71

179.86

3

0.73

 

Myricitrin

464.10

12

8

0.10

165.88

2

0.67

Miquelianin

478.07

13

8

-0.17

178.77

2

0.81

3,5,7,3’5’-Pentahydroxy flavone

302.04

7

5

1.41

104.75

0

-0.52

3’,4’-Di-O-methlquercetin

330.07

7

3

1.73

84.77

0

0.32

Stigmasr-24-enol

414.39

1

1

7.65

17.21

1

0.22

Quercitrin

448.10

11

7

0.32

150.41

2

0.82

Kalanchoside A

562.28

10

5

0.08

127.78

1

0.74

Kalanchoside B

562.28

10

5

0.08

127.78

1

0.74

Kalanchoside C

546.28

9

4

1.02

111.76

1

0.77

Hellebrigenin

416.22

6

3

1.48

81.44

0

0.52

Hellebrigenin-3-acetate

458.23

7

2

1.75

85.98

0

0.83

Methyl daigremonate

502.22

9

2

1.42

94.03

1

0.31

Thesiuside

620.28

12

5

-0.48

149.57

2

0.56

Lanceotoxin A

620.28

12

5

-0.21

153.43

2

0.72

Lanceotoxin B

604.29

11

4

0.39

132.26

2

0.70

Campesterol

400.37

1

1

7.87

16.28

1

0.59

Diclofenac

295.02

2

2

4.52

35.44

0

0.59

Ibuprofen

206.13

2

1

3.85

28.65

0

0.65

                             

 


Table 2. Pharmacokinetic parameters of selected chemical constituents from Bryophyllum pinnatum

 

Constituent name

CNS

mol MW

dipole

Volume

QPlogPC16

QPlogPoct

QPlogPw

QPlogPo/w

QPlogS

QPlogHERG

QPPCaco

QPlogBB

QPPMDCK

QPlogKp

QPlogKhsa

%HOA

PSA

RO3

RO5

Beta-amyrin

1

426.724

1.954

1380.865

11.587

18.161

4.683

7.054

-8.103

-3.763

4439.036

0.178

2477.379

-2.033

2.051

100

19.872

1

1

Alpha amyrin

1

426.724

1.931

1364.847

11.423

17.959

4.613

6.946

-7.804

-3.517

4436.782

0.188

2476.019

-2.049

2.007

100

19.889

1

1

Friedelin

1

426.724

4.358

1364.717

11.12

17.037

3.583

6.943

-7.902

-3.384

4077.362

0.218

2259.944

-2.269

2.045

100

25.666

1

1

Taraxaerol

1

426.724

1.789

1384.13

11.573

18.169

4.648

7.067

-8.138

-3.751

4435.095

0.177

2475.002

-2.054

2.06

100

19.891

1

1

Beta-amyrin acetate

1

468.762

2.924

1517.883

12.595

18.804

3.712

7.956

-9.41

-4.205

3968.448

0.108

2194.766

-2.129

2.447

100

35.012

1

1

Campesterol

0

400.687

1.78

1425.737

12.221

17.407

3.877

7.266

-8.389

-4.64

3405.954

-0.287

1860.532

-1.739

1.961

100

22.277

1

1

Beta-sitosterol

0

414.713

1.765

1474.934

12.658

17.853

3.697

7.584

-8.557

-4.649

3404.348

-0.348

1859.584

-1.644

2.059

100

22.281

1

1

Hellebrigenin

-2

416.513

8.646

1190.03

11.83

20.82

11.789

2.579

-4.385

-3.735

118.286

-1.389

49.238

-4.576

0.414

79.149

123.445

0

0

Bryophyllin B

-2

488.533

6.272

1329.893

12.985

22.049

12.661

2.463

-4.792

-4.201

57.39

-1.81

22.532

-5.2

0.351

72.844

163.457

0

0

Bryotoxin A

-2

618.677

7.876

1716.851

17.35

33.385

22.483

1.439

-5.109

-5.246

21.116

-2.893

7.646

-5.655

-0.158

33.159

206.64

1

2

Lanceotoxin A

-2

620.692

5.781

1661.693

16.884

32.728

22.231

1.331

-3.659

-4.327

15.629

-2.88

5.523

-5.529

-0.195

30.193

221.267

1

2

Lanceotoxin B

-2

604.693

4.393

1653.599

16.716

33.694

23.667

1.128

-4.325

-4.601

24.98

-2.551

9.169

-5.53

-0.19

32.649

186.113

0

2

Quercetin

-2

302.24

4.815

866.544

10.742

18.57

14.412

0.385

-2.884

-5.075

19.27

-2.38

6.926

-5.492

-0.342

52.195

142.683

1

0

Luteolin

-2

286.24

3.058

841.868

10.202

16.356

12.292

0.948

-3.08

-5.037

42.029

-1.944

16.09

-4.857

-0.194

61.556

121.176

0

0

Quercitrin

-2

448.382

9.141

1202.959

14.541

29.553

23.621

-0.57

-2.955

-5.195

7.312

-3.14

2.43

-6.014

-0.651

13.152

196.616

2

2

Isoquercitrin

-2

464.382

9.237

1230.155

15.252

31.976

26.562

-1.463

-2.46

-5.052

2.363

-3.727

0.717

-6.84

-0.868

0

219.83

2

2

Rutin

-2

610.524

9.435

1603.123

19.765

42.911

36.276

-2.695

-2.605

-5.757

0.368

-5.29

0.096

-8.039

-1.323

0

270.732

2

3

Kaempferol

-2

286.24

4.527

845.228

10.242

16.591

12.327

1.061

-3.142

-5.178

53.753

-1.864

20.992

-4.596

-0.189

64.127

121.15

0

0

Myricitrin

-2

464.382

8.049

1225.617

15.064

31.289

25.718

-1.21

-2.806

-5.121

2.578

-3.709

0.787

-6.923

-0.768

1.304

218.087

2

2

Astragalin

-2

448.382

5.772

1187.782

14.409

29.053

24.315

-0.779

-2.524

-5.176

11.203

-2.963

3.854

-5.486

-0.801

15.249

190.508

2

2

Afzelin

-2

432.383

4.327

1186.608

14.107

26.944

21.569

-0.019

-3.183

-5.312

15.273

-2.754

5.388

-5.397

-0.535

35.063

175.169

1

1

3,5,7,3’,5’-pentahydroxyflavone

-2

302.24

6.281

867.872

10.759

18.848

14.424

0.331

-2.903

-5.065

16.313

-2.458

5.785

-5.655

-0.341

50.585

143.684

1

0

Kaempferitrin

-2

578.526

4.296

1564.664

18.461

37.809

31.02

-1.182

-3.541

-6.043

3.219

-4.192

1.001

-6.446

-0.999

0

229.912

2

3

3’,4’--Di-O-methlquercetin

-2

330.293

4.79

975.668

10.384

16.462

10.693

2.041

-3.933

-5.126

177.367

-1.493

76.291

-3.733

0.03

79.147

114.424

0

0

Bryophyllin A

-1

472.534

5.716

1254.453

12.028

23.028

14.885

2.076

-3.834

-3.577

360.668

-0.872

164.299

-3.739

0.075

84.867

124.681

0

0

Bryotoxin B

-2

488.533

4.386

1265.648

12.49

25.244

17.963

1.287

-3.449

-3.646

224.212

-1.127

98.285

-4.046

-0.167

76.551

138.104

0

0

Glutinol

1

426.724

1.748

1379.987

11.52

18.144

4.602

7.072

-7.927

-3.552

4853.539

0.222

2728.337

-1.973

2.05

100

19.408

1

1

Kalanchoside A

-2

562.656

8.254

1548.817

15.687

31.361

21.234

1.489

-4.315

-4.448

35.574

-2.341

13.437

-5.233

-0.052

50.469

175.938

0

1

Kalanchoside B

-2

562.656

6.924

1546.923

15.707

31.133

21.261

1.512

-4.399

-4.596

40.135

-2.329

15.308

-5.105

-0.069

51.541

175.222

0

1

Miquelianin

-2

478.365

6.804

1244.59

15.539

30.41

25.021

-0.816

-2.851

-3.414

0.241

-4.129

0.077

-7.661

-0.895

0

246.272

2

2

Thesiuside

-2

620.692

8.989

1683.402

17.35

36.613

26.548

0.413

-3.73

-4.56

14.497

-2.895

5.092

-5.8

-0.446

24.232

210.131

1

2

Kalachoside C

-2

546.656

5.82

1526.798

15.09

28.506

18.121

2.289

-4.789

-4.434

63.047

-2.029

24.942

-4.844

0.208

59.602

155.104

0

1

Bryophyllin C

-1

474.55

3.867

1257.87

12.245

23.889

15.798

2.167

-3.866

-3.578

406.584

-0.887

187.02

-3.542

0.119

86.332

115.432

0

0

Stigmast-24-enol

0

414.713

1.698

1464.005

12.294

17.545

3.437

7.527

-8.391

-4.425

3934.713

-0.276

2174.606

-1.622

2.028

100

21.086

1

1

Hellebrigenin-3-acetate

-2

458.55

7.076

1316.669

12.59

20.88

10.695

3.383

-5.278

-4.116

139.862

-1.419

59.014

-4.444

0.665

85.158

136.847

0

0

Alpha amyrin acetate

1

468.762

3.077

1498.919

12.255

18.525

3.525

7.813

-8.974

-3.807

4005.432

0.129

2216.882

-2.188

2.392

100

34.327

1

1

Pseudotaraxasterol

1

426.724

1.543

1374.933

11.568

18.102

4.7

7.05

-7.995

-3.722

4793.982

0.212

2692.169

-1.939

2.035

100

19.515

1

1

Methyl daigremonate

-2

502.56

6.571

1385.556

12.896

24.483

15.394

2.222

-4.367

-4.321

300.94

-1.311

135.098

-3.75

-0.011

71.356

131.263

0

1


CONCLUSION

Bryophyllum pinnatum, a medicinal herb, is used in the treatment of various ailments due to the presence of a variety of chemical constituents. Around thirty-eight selected chemical constituents were screened for physicochemical and pharmacokinetic parameters. The physicochemical properties and drug likeness of selected chemical constituents were assessed by using Molsoft software.  The selected chemical constituents were then estimated for pharmacokinetic parameters by QikProp module of Schrodinger molecular modeling software. Maximum of the selected chemical constituents showed values ranging within the recommended values. This indicates that most of the selected chemical constituents have a potential of becoming lead molecules with potent anti-inflammatory activity and good oral bioavailability.

REFERENCES

  1. Okoye EI, Anyaegbunam LC, Obi ZC, Ibemenuga KN. Pharmaceutical constituents of stem of Bryophyllum pinnatum. Magnesium. 2013;11:1-38.
  2.  Kalanchoe pinnata. https://en.wikipedia.org/wiki/Kalanchoe pinnata
  3. Sadhana D, Parveen S, Bukhari NI, Shehzadi N, Qamar S, Ijaz A, Niazi SU, Naheed S, Latif A. Bryophyllum pinnatum: botanical description, vernacular names, parts used, traditional uses, phytochemical and phrmacological activities. Pakistan Journal of Pharmacy. 2018 Nov 6;30(1).
  4. Yadav P, Mishra AK, Singh H. A Recent Review On Chemistry And Biological Activities Of Bryophyllum Pinatum (Lam.) Oken Family: Crassulaceae. Oriental Journal Of Chemistry. 2021;37(2):269.
  5. Orisakeye OT, Oladoye SO, Peters OA. Chemical Composition and Antioxidant Activity of Bryophyllum pinnatum Root. Natural Products Chemistry & Research. 2015;3(3):1-3.
  6. Uchegbu RI, Ahuchaogu AA, Amanze KO, Ibe CO. Chemical constituents analysis of the leaves of Bryophyllum pinnatum by GC-MS. AASCIT J. Chem. 2017;3:19-22.
  7. Fürer K, Simões-Wüst AP, von Mandach U, Hamburger M, Potterat O. Bryophyllum pinnatum and related species used in anthroposophic medicine: constituents, pharmacological activities, and clinical efficacy. Planta medica. 2016 Jul;82(11/12):930-41.
  8. Chibli LA, Rodrigues KC, Gasparetto CM, Pinto NC, Fabri RL, Scio E, Alves MS, Del-Vechio-Vieira G, Sousa OV. Anti-inflammatory effects of Bryophyllum pinnatum (Lam.) Oken ethanol extract in acute and chronic cutaneous inflammation. Journal of ethnopharmacology. 2014 Jun 11;154(2):330-8.
  9. Muhammad Afzal MA, Gaurav Gupta GG, Imran Kazmi IK, Mahfoozur Rahman MR, Obaid Afzal OA, Jahangir Alam JA, Hakeem KR, Mohammad Pravez MP, Ritu Gupta RG, Firoz Anwar FA. Anti-inflammatory and analgesic potential of a novel steroidal derivative from Bryophyllum pinnatum.
  10. Ogidigo JO, Anosike C, Nwodo OF, Omotuyi O, Nash O, Metibemu S, Eniafe G, Okpalafe O, Sani M. In silico molecular docking and pharmacokinetic studies of some selected phyto-constituents of Byrophyllum pinnatum as a potential selective inhibitor of MAO-B. Pharmacologyonline. 2018 Dec 30;3(45):14-49.
  11. Wikipedia contributors, Lipinski rule of 5. Wikipedia, The Free Encyclopedia. https://en.wikipedia.org/wiki/Lipinski's rule of five
  12. Drug bank. Lipinski rule of 5. https://dev.drugbank.com/guides/terms/ lipinski’s rule of five.
  13. Vrbanac J, Slauter R. ADME in drug discovery. InA comprehensive guide to toxicology in nonclinical drug development 2017 Jan 1 (pp. 39-67). Academic Press.
  14. North east biolab. ADME studies: Measuring drug viability and suitability for later development. https://www.nebiolab.com/adme-studies/
  15. Tripathi KD. Essentials of medical pharmacology. Jaypee Brothers medical publishers; 2018 Oct 31.

Reference

  1. Okoye EI, Anyaegbunam LC, Obi ZC, Ibemenuga KN. Pharmaceutical constituents of stem of Bryophyllum pinnatum. Magnesium. 2013;11:1-38.
  2.  Kalanchoe pinnata. https://en.wikipedia.org/wiki/Kalanchoe pinnata
  3. Sadhana D, Parveen S, Bukhari NI, Shehzadi N, Qamar S, Ijaz A, Niazi SU, Naheed S, Latif A. Bryophyllum pinnatum: botanical description, vernacular names, parts used, traditional uses, phytochemical and phrmacological activities. Pakistan Journal of Pharmacy. 2018 Nov 6;30(1).
  4. Yadav P, Mishra AK, Singh H. A Recent Review On Chemistry And Biological Activities Of Bryophyllum Pinatum (Lam.) Oken Family: Crassulaceae. Oriental Journal Of Chemistry. 2021;37(2):269.
  5. Orisakeye OT, Oladoye SO, Peters OA. Chemical Composition and Antioxidant Activity of Bryophyllum pinnatum Root. Natural Products Chemistry & Research. 2015;3(3):1-3.
  6. Uchegbu RI, Ahuchaogu AA, Amanze KO, Ibe CO. Chemical constituents analysis of the leaves of Bryophyllum pinnatum by GC-MS. AASCIT J. Chem. 2017;3:19-22.
  7. Fürer K, Simões-Wüst AP, von Mandach U, Hamburger M, Potterat O. Bryophyllum pinnatum and related species used in anthroposophic medicine: constituents, pharmacological activities, and clinical efficacy. Planta medica. 2016 Jul;82(11/12):930-41.
  8. Chibli LA, Rodrigues KC, Gasparetto CM, Pinto NC, Fabri RL, Scio E, Alves MS, Del-Vechio-Vieira G, Sousa OV. Anti-inflammatory effects of Bryophyllum pinnatum (Lam.) Oken ethanol extract in acute and chronic cutaneous inflammation. Journal of ethnopharmacology. 2014 Jun 11;154(2):330-8.
  9. Muhammad Afzal MA, Gaurav Gupta GG, Imran Kazmi IK, Mahfoozur Rahman MR, Obaid Afzal OA, Jahangir Alam JA, Hakeem KR, Mohammad Pravez MP, Ritu Gupta RG, Firoz Anwar FA. Anti-inflammatory and analgesic potential of a novel steroidal derivative from Bryophyllum pinnatum.
  10. Ogidigo JO, Anosike C, Nwodo OF, Omotuyi O, Nash O, Metibemu S, Eniafe G, Okpalafe O, Sani M. In silico molecular docking and pharmacokinetic studies of some selected phyto-constituents of Byrophyllum pinnatum as a potential selective inhibitor of MAO-B. Pharmacologyonline. 2018 Dec 30;3(45):14-49.
  11. Wikipedia contributors, Lipinski rule of 5. Wikipedia, The Free Encyclopedia. https://en.wikipedia.org/wiki/Lipinski's rule of five
  12. Drug bank. Lipinski rule of 5. https://dev.drugbank.com/guides/terms/ lipinski’s rule of five.
  13. Vrbanac J, Slauter R. ADME in drug discovery. InA comprehensive guide to toxicology in nonclinical drug development 2017 Jan 1 (pp. 39-67). Academic Press.
  14. North east biolab. ADME studies: Measuring drug viability and suitability for later development. https://www.nebiolab.com/adme-studies/
  15. Tripathi KD. Essentials of medical pharmacology. Jaypee Brothers medical

Photo
Ketura Kambampaty
Corresponding author

Department of Pharmaceutics, Maratha Mandal College of Pharmacy

Photo
Dr Preeti Salve
Co-author

Department of Pharmaceutical Chemistry, KLE college of Pharmacy, Belgaum

Photo
Nurzeba Bepari
Co-author

Department of Pharmaceutics, Rani Chennamma College of Pharmacy, Belgaum

Ketura Kambampaty*1, Dr. Preeti Salve2, Nurzeba Bepari3, Virtual Screening of Physicochemical and Pharmacokinetic Parameters of Selected Bryophyllum Pinnatum Constituents, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 1, 1850-1862. https://doi.org/10.5281/zenodo.14717214

More related articles
The pharmacognostic study, phytochemical screening...
Namrata M. Waghmare , Manisha G. Pate, Jayshree S. Dalal, Prasad ...
Molecular Simulation and Computational Docking Bas...
Sathish N. K., Sharanagouda, Dhananjay Mathad, V. V. S. Rajendra ...
Review on Phenoxybenzamine for Veterinary Use ...
Pommala Nagaveni, Ulava Mahendra Chowdary, Rachamreddy Supriya, G...
In-Silico Characterization, ADMET Prediction, and Molecular Docking Studies of C...
Swapnil Tirmanwar, Pratik Dhokane, Shivani Wadichar, Saurabh Kolaskar, Gopal Pondhe, Kajal Prasad, ...
Review On Pharmacological Avtivity Of Bryophyllum Pinnatum...
Priya R. Kamble, Prajakta Devkate, Jaya Kamble, Pritam Salokhe, N. B. Chougule, ...
Design and In Silico Study of 3,5-Dinitrocatechol and Its Derivatives for Antipa...
D. P. Kawade, Y. S. Bhattad, S. R. Shahu, S. G. Kshirsagar, S.R. Bagh, ...
Related Articles
Aspirin Redesigned: A CADD-Guided Exploration of Optimized Aspirin Analogs for T...
Ranjeet V Pingale , Raj R Jagtap , Rohan B chavan , Pratik B lakade, ...
Navigating The Landscape Of Liposome-Based Drug Delivery Systems : A Comprehensi...
Bansode Krushna, Wankhede Jayshri, Vyawhare Pankaj, Shewale Madhu, ...
The pharmacognostic study, phytochemical screening, and TLC of Allamanda Cathart...
Namrata M. Waghmare , Manisha G. Pate, Jayshree S. Dalal, Prasad P. Jumde , ...
More related articles
The pharmacognostic study, phytochemical screening, and TLC of Allamanda Cathart...
Namrata M. Waghmare , Manisha G. Pate, Jayshree S. Dalal, Prasad P. Jumde , ...
Molecular Simulation and Computational Docking Based Synthesis and Screening of ...
Sathish N. K., Sharanagouda, Dhananjay Mathad, V. V. S. Rajendra prasad, Jaishree V. A., Bhagyashree...
Review on Phenoxybenzamine for Veterinary Use ...
Pommala Nagaveni, Ulava Mahendra Chowdary, Rachamreddy Supriya, Gajula Vinunthna Grace, Devireddy Ha...
The pharmacognostic study, phytochemical screening, and TLC of Allamanda Cathart...
Namrata M. Waghmare , Manisha G. Pate, Jayshree S. Dalal, Prasad P. Jumde , ...
Molecular Simulation and Computational Docking Based Synthesis and Screening of ...
Sathish N. K., Sharanagouda, Dhananjay Mathad, V. V. S. Rajendra prasad, Jaishree V. A., Bhagyashree...
Review on Phenoxybenzamine for Veterinary Use ...
Pommala Nagaveni, Ulava Mahendra Chowdary, Rachamreddy Supriya, Gajula Vinunthna Grace, Devireddy Ha...